Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Companies
  4. /
  5. Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT – FDA Inspections
Company
•United States

Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT – FDA Inspections

Inspection records and compliance data for Boehringer Ingelheim Pharmaceuticals, Inc. in Ridgefield, Connecticut. 20 FDA inspections on record, 5 Form 483s, last inspected August 25, 2026.

Sign in to open in Dashboard
Company Profile

This profile covers Boehringer Ingelheim Pharmaceuticals, Inc. based in Ridgefield, Connecticut, United States.

FDA Inspection History

FDA inspections
20
OAI
0
VAI
6
NAI
10
Unclassified
4
Form 483s
5
Warning letters
0

First inspected June 15, 2010. Last inspected August 25, 2026.

Most cited issue areas

  • General responsibilities of sponsors3 inspections
  • Ensuring compliance with plan and protocol2 inspections
  • Failure to develop written procedures1 inspection

FDA inspections (20)

DateResultFDA center(s)Insp. #
August 25, 2026Not classifiedHuman Drugs1334848
September 11, 2025VAIHuman Drugs · Bioresearch Monitoring: Human Drugs1281125
May 2, 2024Not classifiedBiologics1235545
September 22, 2023NAIHuman Drugs · Bioresearch Monitoring1219707
December 12, 2019VAIHuman Drugs · Bioresearch Monitoring1112627
December 6, 2018VAIHuman Drugs · Bioresearch Monitoring1073537
July 3, 2018Not classifiedHuman Drugs1066876
July 28, 2017Not classifiedHuman Drugs · Postmarket Surv. and Epidemiology1019749
February 28, 2017VAIHuman Drugs · Bioresearch Monitoring1004536
February 26, 2016NAIHuman Drugs · Bioresearch Monitoring963057
July 24, 2014NAIHuman Drugs · Bioresearch Monitoring897741
December 18, 2013NAIHuman Drugs · Bioresearch Monitoring861960
March 28, 2013NAIHuman Drugs · Bioresearch Monitoring830047
January 30, 2013VAIHuman Drugs · Bioresearch Monitoring816303
December 3, 2012NAIHuman Drugs · Bioresearch Monitoring809380
April 7, 2011NAIHuman Drugs · Drug Quality Assurance720668
February 3, 2011NAIHuman Drugs · Bioresearch Monitoring714250
September 27, 2010NAIHuman Drugs · Drug Quality Assurance682324
September 1, 2010VAIHuman Drugs · Bioresearch Monitoring678092
June 15, 2010NAIHuman Drugs · Bioresearch Monitoring667641
FDA documents

Form 483s (2)

  • Form 483s · September 11, 2025
  • Form 483s · December 12, 2019

EIRs (1)

  • EIRs · September 1, 2010
People (5)
Michelle M. Noe
Person
M. Patricia Murphy
Person
Miah Jung
Person
Cynthia Kleppinger
Person
Kent A. Conforti
Person
Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

Pharmacyclics LLC
Gilead Sciences Inc
SC Johnson Professional USA, Inc.
Pfizer Inc.
Rajinder S. Shiwach, M.D.
Janssen Pharmaceuticals, dba Actelion Pharmaceutical
BioTel Research, LLC
Andrew C Sedillo, MD
Bausch Health Americas, Inc.
Bristol-Myers Squibb Company
Company Information

Name

Boehringer Ingelheim Pharmaceuticals, Inc.

FEI Number

1219205

Address

900 Ridgebury Rd, Ridgefield, Connecticut 06877, United States

Country

United States

ID: 437c28a1-054f-4c22-9dba-fd40af58a7be

KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.